[Protease inhibitors in the treatment of pancreatitis].
Takeda
K
K
First Department of Surgery, Tohoku University, School of Medicine.
D000208:Acute Disease; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use; D002908:Chronic Disease; D004952:Esters; D016670:Gabexate / Q000627:therapeutic use; D006023:Glycoproteins / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D010195:Pancreatitis / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D014361:Trypsin Inhibitors / Q000627:therapeutic use
D004952:Esters; D006023:Glycoproteins; D006146:Guanidines; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; C034532:camostat; D016670:Gabexate; D007611:Aprotinin; C028665:urinastatin